Last reviewed · How we verify

NCT05060874: HANDGAGES

Gripwise® Versus JAMAR®

Completed Last updated 30 November 2021
What this trial tests

trial in Age-Related Sarcopenia in 348 participants. Completed in 18 November 2021.

Timeline
1 September 2021
Primary endpoint
1 September 2021
18 November 2021

Quick facts

Lead sponsorUniversity Hospital, Caen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment348
Start date1 September 2021
Primary completion1 September 2021
Estimated completion18 November 2021
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Caen

Who can join

65 and older, any sex, with Age-Related Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement. Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones. This cross-sectional study will include 348 patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Gripwise Versus Jamar: The Challenge of a New Dynamometer Assessing Handgrip Strength.
    Villain C, Lebaube S, Kremer C, Chavoix C, et al · · 2023 · cited 6× · PMID 37578949 · DOI 10.1093/gerona/glad198

Verify or expand the search:

Other recruiting trials for Age-Related Sarcopenia

Currently open trials in the same condition.

Other University Hospital, Caen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05060874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing